What is AdaptHealth's cash & equivalents?

AdaptHealth (AHCO) reported cash & equivalents of $47.96M in Q1 2026.

How has AdaptHealth's cash & equivalents changed year-over-year?

AdaptHealth's cash & equivalents decreased by 10.6% year-over-year, from $53.65M to $47.96M.

What is the long-term trend for AdaptHealth's cash & equivalents?

Over 5 years (2020 to 2025), AdaptHealth's cash & equivalents has grown at a 1.2% compound annual growth rate (CAGR), from $99.96M to $106.14M.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

AdaptHealth AHCO Cash & Equivalents

Cash & Equivalents at other companies

CVS HealthCVS

$9.77B-5.6%

Cardinal HealthCAH

$3.94B+18.4%

BrightSpring Health Services, Inc.BTSG

$888.8M+1,598%

Aveanna Healthcare Holdings Inc.AVAH

$189.27M+165%

The Pennant Group, Inc.PNTG

$4.91M-5.9%

ResMedRMD

$1.66B+78.0%

Other financials

Income statement

See full

Revenue$819.8M+5.4%

Gross profit$111.5M-7.4%

Operating income$5.5M-76.3%

Net income-$16.0M-123%

EPS (diluted)-$0.12-140%

Balance sheet

See full

Total debt$2.0B-4.9%

Total equity$1.5B-3.9%

Total assets$4.4B-0.3%

Cash flow

See full

Operating cash flow$93.7M-1.9%

CapEx$121.2M+26.8%

Free cash flow-$27.5M-47,297%

Valuation

See full

Market cap$1.36B+10.6%

Enterprise value$3.32B+1.7%

P/S0.4×0.0×

Profitability

See full

Gross margin18.3%-1.6pp

Operating margin8%+6.9pp

Net margin-2.4%-5.1pp

FCF margin5.8%-2.6pp

Returns & leverage

See full

Return on equity-5.2%-10.8pp

Debt / equity1.3×0.0×

Current ratio0.9×-0.4×

Where this comes from

Reported directly by AdaptHealth in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: AdaptHealth’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about AdaptHealth's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AdaptHealth's cash & equivalents?: AdaptHealth (AHCO) reported cash & equivalents of $47.96M in Q1 2026.
How has AdaptHealth's cash & equivalents changed year-over-year?: AdaptHealth's cash & equivalents decreased by 10.6% year-over-year, from $53.65M to $47.96M.
What is the long-term trend for AdaptHealth's cash & equivalents?: Over 5 years (2020 to 2025), AdaptHealth's cash & equivalents has grown at a 1.2% compound annual growth rate (CAGR), from $99.96M to $106.14M.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.